Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Offin

Showing results (81-90 of 88) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 88 results.
Lung Cancer (Amsterdam, Netherlands)|October 9, 2021
Corrigendum to "Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusions" [Lung Cancer 159 (2021) 66-73]Sebastian Mondaca, Emily S Lebow, Azadeh Namakydoust, et al.
Lung Cancer (Amsterdam, Netherlands)|July 26, 2021
Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusionsSebastian Mondaca, Emily S Lebow, Azadeh Namakydoust, et al.
Cancer Discovery|June 22, 2021
Multiomic Analysis of Lung Tumors Defines Pathways Activated in Neuroendocrine TransformationAlvaro Quintanal-Villalonga, Hirokazu Taniguchi, Yingqian A Zhan, et al.
Journal of the National Cancer Institute|November 30, 2018
A Prospective Study of Circulating Tumor DNA to Guide Matched Targeted Therapy in Lung CancersJoshua K Sabari, Michael Offin, Dennis Stephens, et al.
The Lancet. Oncology|October 2, 2025
First-line immunotherapy with or without chemotherapy versus BRAF plus MEK inhibitors in BRAF<sup>V600E</sup>-mutated metastatic non-small-cell lung cancer (FRONT-BRAF): a multicentre, retrospective cohort studyAlessandro Di Federico, Kaiwen Wang, Monica F Chen, et al.
Cancer Discovery|March 28, 2020
HER2-Mediated Internalization of Cytotoxic Agents in <i>ERBB2</i> Amplified or Mutant Lung CancersBob T Li, Flavia Michelini, Sandra Misale, et al.
Cancer Discovery|August 26, 2024
Chromothripsis-Mediated Small Cell Lung CarcinomaNatasha Rekhtman, Sam E Tischfield, Christopher A Febres-Aldana, et al.
Nature Medicine|November 10, 2022
Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancerJustin Jee, Emily S Lebow, Randy Yeh, et al.
Pageof 9

Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Lung Cancer (Amsterdam, Netherlands)|October 9, 2021
Corrigendum to "Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusions" [Lung Cancer 159 (2021) 66-73]Sebastian Mondaca, Emily S Lebow, Azadeh Namakydoust, et al.
Lung Cancer (Amsterdam, Netherlands)|July 26, 2021
Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusionsSebastian Mondaca, Emily S Lebow, Azadeh Namakydoust, et al.
Cancer Discovery|June 22, 2021
Multiomic Analysis of Lung Tumors Defines Pathways Activated in Neuroendocrine TransformationAlvaro Quintanal-Villalonga, Hirokazu Taniguchi, Yingqian A Zhan, et al.
Journal of the National Cancer Institute|November 30, 2018
A Prospective Study of Circulating Tumor DNA to Guide Matched Targeted Therapy in Lung CancersJoshua K Sabari, Michael Offin, Dennis Stephens, et al.
The Lancet. Oncology|October 2, 2025
First-line immunotherapy with or without chemotherapy versus BRAF plus MEK inhibitors in BRAF<sup>V600E</sup>-mutated metastatic non-small-cell lung cancer (FRONT-BRAF): a multicentre, retrospective cohort studyAlessandro Di Federico, Kaiwen Wang, Monica F Chen, et al.
Cancer Discovery|March 28, 2020
HER2-Mediated Internalization of Cytotoxic Agents in <i>ERBB2</i> Amplified or Mutant Lung CancersBob T Li, Flavia Michelini, Sandra Misale, et al.
Cancer Discovery|August 26, 2024
Chromothripsis-Mediated Small Cell Lung CarcinomaNatasha Rekhtman, Sam E Tischfield, Christopher A Febres-Aldana, et al.
Nature Medicine|November 10, 2022
Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancerJustin Jee, Emily S Lebow, Randy Yeh, et al.
Pageof 9